Evaluation of SARS-CoV-2 Antibodies and the Impact of COVID-19 on the HIV Care Continuum, Economic Security, Risky Health Behaviors, and Mental Health Among HIV-Infected Individuals in Vietnam.

Evaluation of SARS-CoV-2 Antibodies and the Impact of COVID-19 on the HIV Care Continuum, Economic Security, Risky Health Behaviors, and Mental Health Among HIV-Infected Individuals in Vietnam.
复制标题

DOI:
10.1007/s10461-021-03464-w
复制
发表时间:
2022-04
期刊:
影响因子:
4.4
通讯作者:
Oka S
Oka S
中科院分区:
医学2区
文献类型:
--
作者:
Matsumoto S;Nagai M;Luong DAD;Nguyen HDT;Nguyen DT;Van Dinh T;Van Tran G;Tanuma J;Pham TN;Oka S

文献摘要

参考文献

被引文献

相似文献

2019冠状病毒病(COVID-19)和相关的社会反应可能对艾滋病毒感染者(PLHIV)产生独特影响。在越南河内的一个大型PLHIV队列中进行了SARS-CoV-2抗体检测和COVID-19社会行为影响的横断面调查。我们对1243名PLHIV(99.8%)的匿名抗体检测结果进行了检查,并于2020年6月/ 7月(即第一次COVID-19疫情和全国封锁刚刚结束之后)收集了血浆,并完成了调查。3名参与者(0.2%)抗sars - cov -2 IgG抗体检测呈阳性。艾滋病毒治疗总体上得到维持,没有中断抗逆转录病毒治疗,但COVID-19对艾滋病毒感染者的经济安全和危险健康行为产生了实质性影响,这可能加剧了心理压力。这些发现突出表明,需要持续监测COVID-19对艾滋病毒感染者的影响,并努力减轻这些影响。在线版本包含补充材料,可在10.1007/s10461-021-03464-w获得。
Coronavirus disease 2019 (COVID-19) and associated social responses may uniquely affect people living with HIV (PLHIV). SARS-CoV-2 antibody testing and a cross-sectional survey on COVID-19’s socio-behavioral impacts were conducted among a large PLHIV cohort in Hanoi, Vietnam. We examined anonymous antibody test results for 1243 PLHIV (99.8%) from whom plasma was obtained and completed surveys were collected in June/July 2020, just after the end of the first COVID-19 outbreak and nationwide lockdown. Three participants (0.2%) tested positive for anti-SARS-CoV-2 IgG antibodies. HIV treatment was generally maintained without antiretroviral therapy interruption, but COVID-19 had substantial impacts on economic security and risky health behaviors among PLHIV, which may have amplified psychological stress. These findings highlight the need for continuous monitoring of COVID-19’s impacts on PLHIV and for efforts to mitigate these impacts. The online version contains supplementary material available at 10.1007/s10461-021-03464-w.
DOI: 10.1016/j.eclinm.2020.100483
发表时间: 2020-09
期刊: EClinicalMedicine
影响因子: 15.1
作者:
Jewell BL;Smith JA;Hallett TB
通讯作者: Hallett TB
DOI: 10.1371/journal.pone.0180557
发表时间: 2017
期刊: PloS one
影响因子: 3.7
作者:
Le MTH;Tran TD;Holton S;Nguyen HT;Wolfe R;Fisher J
通讯作者: Fisher J
DOI: 10.1007/s42399-020-00593-6
发表时间: 2020
期刊: SN comprehensive clinical medicine
影响因子: --
作者:
Morani Z;Patel S;Ghosh S;Hassan FA;Doreswamy S;Singh S;Kothapudi VN;Desai R
通讯作者: Desai R
DOI: 10.1007/s40615-020-00833-4
发表时间: 2020-09-01
影响因子: 3.9
作者:
Abedi, Vida;Olulana, Oluwaseyi;Zand, Ramin
通讯作者: Zand, Ramin
DOI: 10.7326/m20-3689
发表时间: 2020-10-06
影响因子: 39.2
作者:
del Amo, Julia;Polo, Rosa;Hernan, Miguel A.
通讯作者: Hernan, Miguel A.